You missed out on BAL. Good work on LYC. Make sure you don't get suspended, we want to hear your views on stocks to buy short term. Whether we trust you or not is another question.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025